Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1985 Jun;61(3):190–196. doi: 10.1136/sti.61.3.190

Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.

M Väyrynen, K Syrjänen, R Mäntyjärvi, O Castrén, S Saarikoski
PMCID: PMC1011801  PMID: 2989155

Abstract

From 1981 286 women were prospectively followed up for a mean (SD) of 16 (14) months for established infection with human papillomavirus (HPV) with or without coexistent cervical intraepithelial neoplasia (CIN). The in situ immunocompetent cell infiltrates in 263 cervical punch biopsy specimens from these women were phenotypically identified by the avidinbiotin peroxidase complex (ABC) technique using monoclonal antibodies Leu-10, OKT-3, OKT-4, and OKT-8. Leu-10+ B lymphocytes far outnumbered the OKT-3+ T lymphocytes in all types of HPV lesions (flat, inverted, and papillomatous condylomas of the cervix). The ratio of OKT-4+ to OKT-8+ (T helper to T suppressor cells) was slightly reduced in HPV lesions with more severe CIN and correlated positively with the intensity of the immunocompetent cell infiltrate. The ratio of OKT-4+ to OKT-8+ cells was highest in the 47 (28.8%) patients with HPV lesions that regressed during follow up, somewhat lower in the 85 (52.1%) with persistent lesions, and lowest in the 31 (19.1%) with lesions showing clinical progression. The results are discussed in terms of the proposed immune surveillance functions attributed to immunocompetent cells in situ according to the mucosal associated lymphatic tissue (MALT) concept. The conclusion drawn is that a dynamic balance between the immunoregulatory cells and their subtypes is a prerequisite for the proper handling of intracellular infections of the mucosa, including that with HPV.

Full text

PDF
190

Images in this article

192Image
on p.192
192Image
on p.192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird P. J. Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet. 1983 Jul 2;2(8340):17–18. doi: 10.1016/s0140-6736(83)90006-5. [DOI] [PubMed] [Google Scholar]
  2. Barnett N., Mak H., Winkelstein J. A. Extensive verrucosis in primary immunodeficiency diseases. Arch Dermatol. 1983 Jan;119(1):5–7. [PubMed] [Google Scholar]
  3. Chardonnet Y., Beauve P., Viac J., Schmitt D. T-cell subsets and Langerhans cells in wart lesions. Immunol Lett. 1983 Apr;6(4):191–196. doi: 10.1016/0165-2478(83)90002-0. [DOI] [PubMed] [Google Scholar]
  4. Chretien J. H., Esswein J. G., Garagusi V. F. Decreased T cell levels in patients with warts. Arch Dermatol. 1978 Feb;114(2):213–215. [PubMed] [Google Scholar]
  5. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812–3815. doi: 10.1073/pnas.80.12.3812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Engelhart M., Kristensen J. K. Evaluation of cutaneous blood flow responses by 133Xenon washout and a laser-Doppler flowmeter. J Invest Dermatol. 1983 Jan;80(1):12–15. doi: 10.1111/1523-1747.ep12530879. [DOI] [PubMed] [Google Scholar]
  7. Fletcher S., Norval M. On the nature of the deep cellular disturbances in human-papilloma-virus infection of the squamous cervical epithelium. Lancet. 1983 Sep 3;2(8349):546–549. doi: 10.1016/s0140-6736(83)90573-1. [DOI] [PubMed] [Google Scholar]
  8. Fu Y. S., Braun L., Shah K. V., Lawrence W. D., Robboy S. J. Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. Cancer. 1983 Nov 1;52(9):1705–1711. doi: 10.1002/1097-0142(19831101)52:9<1705::aid-cncr2820520926>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  9. Gliński W., Obałek S., Jabłońska S., Orth G. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica. 1981;162(3):141–147. doi: 10.1159/000250262. [DOI] [PubMed] [Google Scholar]
  10. Guillet G., Braun L., Shah K., Ferenczy A. Condylomes cervicaux et dysplasie: confrontation histologique et virologique à propos de 100 observations. Ann Dermatol Venereol. 1983;110(1):43–51. [PubMed] [Google Scholar]
  11. Jablonska S., Orth G., Lutzner M. A. Immunopathology of papillomavirus-induced tumors in different tissues. Springer Semin Immunopathol. 1982;5(1):33–53. doi: 10.1007/BF00201955. [DOI] [PubMed] [Google Scholar]
  12. Kienzler J. L., Lemoine M. T., Orth G., Jibard N., Blanc D., Laurent R., Agache P. Humoral and cell-mediated immunity to human papillomavirus type 1 (HPV-1) in human warts. Br J Dermatol. 1983 Jun;108(6):665–672. doi: 10.1111/j.1365-2133.1983.tb01078.x. [DOI] [PubMed] [Google Scholar]
  13. Kossard S., Xenias S. J., Palestine R. F., Scheen S. R., 3rd, Winkelmann R. K. Inflammatory changes in verruca vulgaris. J Cutan Pathol. 1980 Aug;7(4):217–221. doi: 10.1111/j.1600-0560.1980.tb01219.x. [DOI] [PubMed] [Google Scholar]
  14. Lutzner M. A., Orth G., Dutronquay V., Ducasse M. F., Kreis H., Crosnier J. Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet. 1983 Aug 20;2(8347):422–424. doi: 10.1016/s0140-6736(83)90389-6. [DOI] [PubMed] [Google Scholar]
  15. Morison W. L. Cell-mediated immune responses in patients with warts. Br J Dermatol. 1975 Nov;93(5):553–556. doi: 10.1111/j.1365-2133.1975.tb02248.x. [DOI] [PubMed] [Google Scholar]
  16. Obałek S., Gliński W., Haftek M., Orth G., Jabłońska S. Comparative studies on cell-mediated immunity in patients with different warts. Dermatologica. 1980;161(2):73–83. doi: 10.1159/000250336. [DOI] [PubMed] [Google Scholar]
  17. Oguchi M., Komura J., Tagami H., Ofuji S. Ultrastructural studies of spontaneously regressing plane warts. Macrophages attack verruca-epidermal cells. Arch Dermatol Res. 1981;270(4):403–411. doi: 10.1007/BF00403784. [DOI] [PubMed] [Google Scholar]
  18. Purola E. E., Halila H., Vesterinen E. Condyloma and cervical epithelial atypias in young women. Gynecol Oncol. 1983 Aug;16(1):34–40. doi: 10.1016/0090-8258(83)90006-9. [DOI] [PubMed] [Google Scholar]
  19. Reid R., Crum C. P., Herschman B. R., Fu Y. S., Braun L., Shah K. V., Agronow S. J., Stanhope C. R. Genital warts and cervical cancer. III. Subclinical papillomaviral infection and cervical neoplasia are linked by a spectrum of continuous morphologic and biologic change. Cancer. 1984 Feb 15;53(4):943–953. doi: 10.1002/1097-0142(19840215)53:4<943::aid-cncr2820530421>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  20. Schmauz R., Claussen C. P., Cordes B., Owor R. Condylomata acuminata and their possible relation to cancer of the uterine cervix. Case report and geographic observations. Acta Cytol. 1983 Sep-Oct;27(5):533–539. [PubMed] [Google Scholar]
  21. Schneider V., Kay S., Lee H. M. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol. 1983 May-Jun;27(3):220–224. [PubMed] [Google Scholar]
  22. Silverberg S. G., Fernandez F. N. Endolymphatic stromal myosis of the ovary: a report of three cases and literature review. Gynecol Oncol. 1981 Aug;12(1):129–138. doi: 10.1016/0090-8258(81)90104-9. [DOI] [PubMed] [Google Scholar]
  23. Singer A., Walker P. G., McCance D. J. Genital wart virus infections: nuisance or potentially lethal? Br Med J (Clin Res Ed) 1984 Mar 10;288(6419):735–737. doi: 10.1136/bmj.288.6419.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Syrjänen K. J. Current concepts of human papillomavirus infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma. Obstet Gynecol Surv. 1984 May;39(5):252–265. doi: 10.1097/00006254-198405000-00002. [DOI] [PubMed] [Google Scholar]
  25. Syrjänen K. J. Current views on the condylomatous lesions in uterine cervix and their possible relationship to cervical squamous cell carcinoma. Obstet Gynecol Surv. 1980 Nov;35(11):685–694. [PubMed] [Google Scholar]
  26. Syrjänen K. J. Human papillomavirus lesions in association with cervical dysplasias and neoplasias. Obstet Gynecol. 1983 Nov;62(5):617–624. [PubMed] [Google Scholar]
  27. Syrjänen K., Väyrynen M., Castrén O., Mäntyjärvi R., Yliskoski M. The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions. Arch Gynecol. 1984;234(3):189–196. doi: 10.1007/BF00570755. [DOI] [PubMed] [Google Scholar]
  28. Tagami H., Oguchi M., Ofuji S. The phenomenon of spontaneous regression of numerous flat warts: immunohistological studies. Cancer. 1980 May 15;45(10):2557–2563. doi: 10.1002/1097-0142(19800515)45:10<2557::aid-cncr2820451014>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  29. Viac J., Staquet M. J., Miguet M., Chabanon M., Thivolet J. Specific immunity to human papilloma virus (HPV) in patients with genital warts. Br J Vener Dis. 1978 Jun;54(3):172–175. doi: 10.1136/sti.54.3.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. de Brux J., Orth G., Croissant O., Cochard B., Ionesco M. Lésions condylomateuses du col utérin: évolution chez 2 466 patientes. Bull Cancer. 1983;70(5):410–422. [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES